0.5 |
1.5 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
0.2 |
1.0 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
0.2 |
1.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.2 |
1.1 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 |
0.7 |
GO:0015671 |
oxygen transport(GO:0015671) |
0.1 |
0.8 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
0.1 |
0.5 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 |
0.3 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
0.1 |
0.3 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
0.1 |
0.4 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 |
0.3 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
0.1 |
0.4 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) progesterone secretion(GO:0042701) negative regulation of hair follicle development(GO:0051799) positive regulation of ovulation(GO:0060279) |
0.1 |
0.3 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 |
0.3 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 |
0.2 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
0.1 |
0.5 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.1 |
0.8 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 |
1.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
0.1 |
0.4 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
0.1 |
0.4 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
0.1 |
0.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
0.1 |
0.2 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
0.1 |
0.5 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
0.1 |
0.3 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
0.1 |
1.0 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 |
0.1 |
GO:2000974 |
inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
0.0 |
0.1 |
GO:0048819 |
embryonic nail plate morphogenesis(GO:0035880) positive regulation of hair follicle maturation(GO:0048818) regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) frontal suture morphogenesis(GO:0060364) |
0.0 |
0.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
0.0 |
0.1 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
0.0 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.0 |
0.2 |
GO:0090219 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of lipid kinase activity(GO:0090219) |
0.0 |
0.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
0.0 |
0.4 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
0.0 |
0.2 |
GO:0048069 |
eye pigmentation(GO:0048069) |
0.0 |
0.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) protein poly-ADP-ribosylation(GO:0070212) |
0.0 |
0.2 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
0.0 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
0.0 |
0.1 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
0.0 |
0.1 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
0.0 |
0.1 |
GO:0015879 |
carnitine transport(GO:0015879) |
0.0 |
0.1 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
0.0 |
0.4 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
0.0 |
0.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
0.0 |
0.4 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
0.0 |
0.7 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 |
0.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
0.0 |
0.1 |
GO:0046958 |
nonassociative learning(GO:0046958) |
0.0 |
0.1 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
0.0 |
0.1 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 |
0.4 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) maintenance of protein location in nucleus(GO:0051457) |
0.0 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
0.0 |
0.1 |
GO:1900623 |
positive regulation of keratinocyte proliferation(GO:0010838) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 |
0.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
0.0 |
0.1 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
0.0 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
0.0 |
0.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.0 |
0.0 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
0.0 |
0.0 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.0 |
0.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 |
0.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 |
0.4 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 |
0.1 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
0.0 |
0.1 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
0.0 |
0.0 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 |
0.0 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.0 |
0.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
0.0 |
0.2 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
0.0 |
0.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) regulation of motor neuron apoptotic process(GO:2000671) |
0.0 |
0.1 |
GO:0060746 |
parental behavior(GO:0060746) |
0.0 |
0.0 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.0 |
0.3 |
GO:0046677 |
response to antibiotic(GO:0046677) |
0.0 |
0.4 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 |
0.0 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
0.0 |
0.3 |
GO:0002063 |
chondrocyte development(GO:0002063) |